Leszek Niepolski

Dr. Leszek Niepolski

Faculty of Medicine, Poznan University of Medical Sciences, Poznań, Wielkopolskie, Poland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
MMMateusz de Mezer
Mateusz de Mezer
JRJan Rogaliński
Jan Rogaliński
SPStanisław Przewoźny
Stanisław Przewoźny
MCMichał Kazimierz Chojnicki
Michał Kazimierz Chojnicki
LNLeszek Niepolski
Leszek Niepolski
APAgnieszka Przystańska
Agnieszka Przystańska
SERPINA3, also called α-1-antichymotrypsin (AACT, ACT), is one of the inhibitors of serine proteases, one of which is cathepsin G. As an acute-phase protein secreted into the plasma by liver cells, it plays an important role in the anti-inflammatory response and antiviral response. Elevated levels of SERPINA3 have been observed in heart failure and neurological diseases such as Alzheimer’s disease or Creutzfeldt–Jakob disease. Many studies have shown increased expression levels of the SERPINA3 gene in various types of cancer, such as glioblastoma, colorectal cancer, endometrial cancer, breast cancer, or melanoma. In this case, the SERPINA3 protein is associated with an antiapoptotic function implemented by adjusting the PI3K/AKT or MAPK/ERK 1/2 signal pathways. However, the functions of the SERPINA3 protein are still only partially understood, mainly in the context of cancerogenesis, so it seems necessary to summarize the available information and describe its mechanism of action. In particular, we sought to amass the existing body of research focusing on the description of the underlying mechanisms of various diseases not related to cancer. Our goal was to present an overview of the correct function of SERPINA3 as part of the defense system, which unfortunately easily becomes the “Fifth Column” and begins to support processes of destruction.

24 August 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
IMIda J. Malesza
Ida J. Malesza
Joanna Bartkowiak-WieczorekJoanna Bartkowiak-Wieczorek
Joanna Bartkowiak-Wieczorek
JWJakub Jan Winkler-Galicki
Jakub Jan Winkler-Galicki
ANAleksandra Ewa Nowicka
Aleksandra Ewa Nowicka
DDDominika Dzięciołowska
Dominika Dzięciołowska
Edyta MądryEdyta Mądry
Edyta Mądry
Iron is an indispensable nutrient for life. A lack of it leads to iron deficiency anaemia (IDA), which currently affects about 1.2 billion people worldwide. The primary means of IDA treatment is oral or parenteral iron supplementation. This can be burdened with numerous side effects such as oxidative stress, systemic and local-intestinal inflammation, dysbiosis, carcinogenic processes and gastrointestinal adverse events. Therefore, this review aimed to provide insight into the physiological mechanisms of iron management and investigate the state of knowledge of the relationship between iron supplementation, inflammatory status and changes in gut microbiota milieu in diseases typically complicated with IDA and considered as having an inflammatory background such as in inflammatory bowel disease, colorectal cancer or obesity. Understanding the precise mechanisms critical to iron metabolism and the awareness of serious adverse effects associated with iron supplementation may lead to the provision of better IDA treatment. Well-planned research, specific to each patient category and disease, is needed to find measures and methods to optimise iron treatment and reduce adverse effects.

1 September 2016 in Advances in Medical Sciences
Verified
Journal Article
Closed access
LNLeszek Niepolski
Leszek Niepolski
AGAlicja Grzegorzewska
Alicja Grzegorzewska

9 November 2018 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
AGAlicja Grzegorzewska
Alicja Grzegorzewska
LNLeszek Niepolski
Leszek Niepolski
MŚMonika K. Świderska
Monika K. Świderska
AMAdrianna Mostowska
Adrianna Mostowska
ISIreneusz Stolarek
Ireneusz Stolarek
PJPaweł Jagodziński
Paweł Jagodziński
The energy homeostasis-associated gene (ENHO), retinoid X receptor alpha gene (RXRA), and liver X receptor alpha gene (LXRA) are involved in adipogenic/lipogenic regulation. We investigated whether single-nucleotide polymorphisms in these genes (ENHO rs2281997, rs72735260; RXRA rs749759, rs10776909, rs10881578; LXRA rs2279238, rs7120118, rs11039155) are associated with dyslipidaemia, related comorbidities and survival of haemodialysis (HD) patients also tested for T-helper (Th) cell interleukin genes (IL). The study was carried out in 873 HD patients. Dyslipidaemia was diagnosed by the recommendations of the Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines (2003); atherogenic dyslipidaemia was referred to if the TG/HDL cholesterol ratio was equal to or higher than 3.8. Genotyping of ENHO SNPs, LXRA SNPs, and IL12A rs568408 was carried out using HRM analysis. RXRA SNPs, IL12B rs3212227, and IL18 rs360719 were genotyped using PCR-RFLP analysis. The circulating adropin concentration was determined in 126 patients by enzyme-linked immunosorbent assay. Survival probability was analysed using the Kaplan-Meier method in 440 patients followed through 7.5 years. Dyslipidaemia by K/DOQI was diagnosed in 459 patients (91% revealed hyper-LDL- cholesterolaemia), atherogenic dyslipidaemia was diagnosed in 454 patients, and 231 patients were free of dyslipidaemia by both criteria. The variant allele (T) of ENHO rs2281997 was associated with the hyper-LDL cholesterolaemic pattern of dyslipidaemia by K/DOQI. The frequency of atherogenic dyslipidaemia was lower in T-allele bearers than in CC-genotype patients. The rs2281997 T allele was associated with lower cardiovascular mortality in HD patients showing atherogenic dyslipidaemia. ENHO, RXRA, and LXRA showed epistatic interactions in dyslipidaemia. Circulating adropin was lower in atherogenic dyslipidaemia than in non-atherogenic conditions. RXRA rs10776909 was associated with myocardial infarction. Bearers of LXRA rs2279238, rs7120118 or rs11039155 minor alleles showed higher mortality. ENHO SNP positions fell within the same DNase 1 hypersensitivity site expressed in the Th1 cell line. Epistatic interactions occurred between rs2281997 and Th1 IL SNPs (rs360719, rs568408). Atherogenic dyslipidaemia occurs in HD patients in whom ENHO encodes less adropin. ENHO, RXRA, and LXRA SNPs, separately or jointly, are associated with dyslipidaemia, myocardial infarction, and survival in HD patients. Differences in the availability of transcription binding sites may contribute to these associations.

1 September 2016 in Life Sciences
Verified
Journal Article
Closed access
AGAlicja Grzegorzewska
Alicja Grzegorzewska
LNLeszek Niepolski
Leszek Niepolski
AMAdrianna Mostowska
Adrianna Mostowska
WWWojciech Warchoł
Wojciech Warchoł
PJPaweł Jagodziński
Paweł Jagodziński

21 November 2016 in Kidney and Blood Pressure Research
Verified
Journal Article
Open access
AGAlicja Grzegorzewska
Alicja Grzegorzewska
AIAgnieszka Izdebska
Agnieszka Izdebska
LNLeszek Niepolski
Leszek Niepolski
WWWojciech Warchoł
Wojciech Warchoł
PJPaweł Jagodziński
Paweł Jagodziński
Background/Aims: Vitamin D status is announced among factors that may influence physical performance and mental health. Our aim was to evaluate self-reported physical activity, quality of life, psychiatric functioning, and affects with respect to plasma 25-hydroxyvitamin D [25(OH)D] concentrations in HD patients. Methods: The study was carried out in HD patients not receiving vitamin D supplements (n = 112). IPAQ-L, QLI-D, GHQ-28, and PANAS were used in psychological evaluations. Plasma 25(OH)D concentration was determined by a chemiluminescent microparticle immunoassay. Results: Plasma 25(OH)D level was suboptimal in all patients (14.6 ± 4.1 ng/ml). Adjusted correlates of 25(OH)D concentration included the GG genotype of GC rs7041 (β±SE: 1.77± 0.70, P=0.014), female sex (β±SE: -2.19±0.75, P=0.004), and treatment with high flux HD (β±SE: 2.59±0.69, P=0.0003). In adjusted analyses, circulating 25(OH)D showed the independent association with total activity related to domestic and gardening domain (β±SE: 53.2±23.8, P=0.028), and with moderate-intensity activities (β±SE: 54.9±27.4, P=0.048), but not with any of quality of life, psychiatric functioning, or affects measures. Conclusions: Vitamin D status is independently positively associated with physical activity in HD patients. Quality of life and mental health do not seem to be associated with circulating 25(OH)D under condition of its suboptimal levels.